The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer

Shuhei Mayanagi, Tetsuro Onitsuka, Masahiro Nakagawa, Hiroshi Sato, Yuukou Kitagawa, Yasuhiro Tsubosa

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Salvage surgery after definitive chemoradiotherapy for cervical esophageal cancer and hypopharyngeal cancer remains a challenge because of the high rate of complications. The purpose of this study was to evaluate the safety and efficacy of free jejunal transfer as salvage surgery for cervical esophageal cancer and hypopharyngeal cancer after definitive chemoradiotherapy. Methods: We enrolled eight patients with cervical esophageal cancer and 11 patients with hypopharyngeal cancer who underwent free jejunal transfer as salvage surgery following radiotherapy or chemoradiotherapy. In this study, we reviewed the surgical procedures, perioperative complications, and survival rates. Results: The median duration of surgery was 514 min, and the median blood loss was 439 ml. In surgical procedures, the recipient vessels for the anastomosis of the free jejunum consisted of one artery and one vein (63 %), one artery and two veins (5 %), and two arteries and two veins (31 %). The postoperative morbidity rate was 57.9 % (11 patients), with six cases of partial necrosis of the tracheal margin and no cases of graft necrosis or postoperative in-hospital death. The overall 5-year survival rate after surgery was 58.1 %. Conclusions: Our findings suggest that with careful attention to the potential development of necrosis of the tracheal margin, pharyngolaryngoesophagectomy and free jejunal transfer can be safely performed, even in patients who received radiotherapy or chemoradiotherapy.

Original languageEnglish
Pages (from-to)144-149
Number of pages6
JournalWorld Journal of Surgery
Volume38
Issue number1
DOIs
Publication statusPublished - 2014 Jan

Fingerprint

Hypopharyngeal Neoplasms
Esophageal Neoplasms
Uterine Cervical Neoplasms
Chemoradiotherapy
Veins
Necrosis
Arteries
Radiotherapy
Survival Rate
Jejunum
Morbidity
Transplants
Safety

ASJC Scopus subject areas

  • Surgery

Cite this

The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer. / Mayanagi, Shuhei; Onitsuka, Tetsuro; Nakagawa, Masahiro; Sato, Hiroshi; Kitagawa, Yuukou; Tsubosa, Yasuhiro.

In: World Journal of Surgery, Vol. 38, No. 1, 01.2014, p. 144-149.

Research output: Contribution to journalArticle

Mayanagi, Shuhei ; Onitsuka, Tetsuro ; Nakagawa, Masahiro ; Sato, Hiroshi ; Kitagawa, Yuukou ; Tsubosa, Yasuhiro. / The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer. In: World Journal of Surgery. 2014 ; Vol. 38, No. 1. pp. 144-149.
@article{ac13e4b3985b4a11ada033a1c648f4d4,
title = "The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer",
abstract = "Background: Salvage surgery after definitive chemoradiotherapy for cervical esophageal cancer and hypopharyngeal cancer remains a challenge because of the high rate of complications. The purpose of this study was to evaluate the safety and efficacy of free jejunal transfer as salvage surgery for cervical esophageal cancer and hypopharyngeal cancer after definitive chemoradiotherapy. Methods: We enrolled eight patients with cervical esophageal cancer and 11 patients with hypopharyngeal cancer who underwent free jejunal transfer as salvage surgery following radiotherapy or chemoradiotherapy. In this study, we reviewed the surgical procedures, perioperative complications, and survival rates. Results: The median duration of surgery was 514 min, and the median blood loss was 439 ml. In surgical procedures, the recipient vessels for the anastomosis of the free jejunum consisted of one artery and one vein (63 {\%}), one artery and two veins (5 {\%}), and two arteries and two veins (31 {\%}). The postoperative morbidity rate was 57.9 {\%} (11 patients), with six cases of partial necrosis of the tracheal margin and no cases of graft necrosis or postoperative in-hospital death. The overall 5-year survival rate after surgery was 58.1 {\%}. Conclusions: Our findings suggest that with careful attention to the potential development of necrosis of the tracheal margin, pharyngolaryngoesophagectomy and free jejunal transfer can be safely performed, even in patients who received radiotherapy or chemoradiotherapy.",
author = "Shuhei Mayanagi and Tetsuro Onitsuka and Masahiro Nakagawa and Hiroshi Sato and Yuukou Kitagawa and Yasuhiro Tsubosa",
year = "2014",
month = "1",
doi = "10.1007/s00268-013-2229-9",
language = "English",
volume = "38",
pages = "144--149",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer

AU - Mayanagi, Shuhei

AU - Onitsuka, Tetsuro

AU - Nakagawa, Masahiro

AU - Sato, Hiroshi

AU - Kitagawa, Yuukou

AU - Tsubosa, Yasuhiro

PY - 2014/1

Y1 - 2014/1

N2 - Background: Salvage surgery after definitive chemoradiotherapy for cervical esophageal cancer and hypopharyngeal cancer remains a challenge because of the high rate of complications. The purpose of this study was to evaluate the safety and efficacy of free jejunal transfer as salvage surgery for cervical esophageal cancer and hypopharyngeal cancer after definitive chemoradiotherapy. Methods: We enrolled eight patients with cervical esophageal cancer and 11 patients with hypopharyngeal cancer who underwent free jejunal transfer as salvage surgery following radiotherapy or chemoradiotherapy. In this study, we reviewed the surgical procedures, perioperative complications, and survival rates. Results: The median duration of surgery was 514 min, and the median blood loss was 439 ml. In surgical procedures, the recipient vessels for the anastomosis of the free jejunum consisted of one artery and one vein (63 %), one artery and two veins (5 %), and two arteries and two veins (31 %). The postoperative morbidity rate was 57.9 % (11 patients), with six cases of partial necrosis of the tracheal margin and no cases of graft necrosis or postoperative in-hospital death. The overall 5-year survival rate after surgery was 58.1 %. Conclusions: Our findings suggest that with careful attention to the potential development of necrosis of the tracheal margin, pharyngolaryngoesophagectomy and free jejunal transfer can be safely performed, even in patients who received radiotherapy or chemoradiotherapy.

AB - Background: Salvage surgery after definitive chemoradiotherapy for cervical esophageal cancer and hypopharyngeal cancer remains a challenge because of the high rate of complications. The purpose of this study was to evaluate the safety and efficacy of free jejunal transfer as salvage surgery for cervical esophageal cancer and hypopharyngeal cancer after definitive chemoradiotherapy. Methods: We enrolled eight patients with cervical esophageal cancer and 11 patients with hypopharyngeal cancer who underwent free jejunal transfer as salvage surgery following radiotherapy or chemoradiotherapy. In this study, we reviewed the surgical procedures, perioperative complications, and survival rates. Results: The median duration of surgery was 514 min, and the median blood loss was 439 ml. In surgical procedures, the recipient vessels for the anastomosis of the free jejunum consisted of one artery and one vein (63 %), one artery and two veins (5 %), and two arteries and two veins (31 %). The postoperative morbidity rate was 57.9 % (11 patients), with six cases of partial necrosis of the tracheal margin and no cases of graft necrosis or postoperative in-hospital death. The overall 5-year survival rate after surgery was 58.1 %. Conclusions: Our findings suggest that with careful attention to the potential development of necrosis of the tracheal margin, pharyngolaryngoesophagectomy and free jejunal transfer can be safely performed, even in patients who received radiotherapy or chemoradiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84891587167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891587167&partnerID=8YFLogxK

U2 - 10.1007/s00268-013-2229-9

DO - 10.1007/s00268-013-2229-9

M3 - Article

VL - 38

SP - 144

EP - 149

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 1

ER -